According to the classification of World Health Organization, primary adenocarcinomas of the sinonasal tract can be initially classified as salivary and non-salivary types. The latter are further divided into intestinal and non-intestinal types. Sinonasal intestinal-type adenocarcinoma(ITAC) is rare adenocarcinoma subtype, which is closely occupational exposure to hardwood dusts, leather. In this study, we present a case of ITAC in a 68-year-old man. We successfully treated with wide excision and soft tissue reconstruction with free anterolateral thigh flap.

The present study was designed to investigate the antiproliferative activity and molecular mechanisms of Bibimbap in HT-29 human colorectal adenocarcinoma cells. Bibimbap extract inhibited the proliferation of HT-29 cells by 50% at a concentration of 10.1±0.17 mg/mL for 48 h. The population of live cells decreased slightly, and the morphology changed with a reduction in cell volume (pyknosis) with Bibimbap. Treatment with 5 mg/mL of Bibimbap resulted in slight cell shrinkage. Furthermore, as the Bibimbap dose increased to 10 mg/mL, these characteristics were more evident, and HT-29 cells exhibited partial detachment by staining with the DNA-binding dye Hoechst 33342. Flow cytometric analysis by Annexin V and PI double staining showed that Bibimbap increased the levels of apoptosis. Analysis of the mechanism of these events showed that Bibimbap-treated cells exhibited a mitochondria-dependent apoptotic pathway through the modulation of caspase-3, caspase-8, caspase-9, and poly-ADP ribose polymerase, as well as Bax and Bcl-2 expression in dose- and time-dependent manners. Consequently, Bibimbap exerts a significant antiproliferative effect on HT-29 human colorectal adenocarcinoma cells.

장액낭성종양(serous cystic neoplasm)은 1978년 Compagno와 Oertel에 의해 처음으로 분류되었으며, 췌장낭성종양(pancreatic cystic neoplasm) 중 10-16%의 빈도를 나타낸다. 장액낭성종양은 악성화의 위험성이 있는 점액낭성종양(mucinous cystic neoplasm)이나 췌관내유두상점액종양(intraductal papillary mucinous neoplasm, IPMN)과는 달리 악성화의 위험성이 거의 없다고 알려져 있다. 또한 장액낭성종양은 일반적으로 고립 병터로 발견되며 췌장의 다른 낭성종양, 만성 췌장염, 췌장암과 같은 췌장 병변과 같이 존재하는 경우는 매우 드물다. 그중에서도 췌관선암종(pancreatic ductal adenocarcinoma)이 동반되는 경우는 거의 없다고 알려져 있다. 이에 저자들은 고이형성 췌장상피내종양(pancreatic intraepithelial neoplasm, PanIN)이 동반된 장액낭성종양과 인접한 위치에 췌관선암종이 동시에 발견된 증례를 문헌고찰과 함께 보고하고자 한다.

Mucinous adenocarcinoma (MAC) refers to a malignant neoplasm that belongs to a subtype of adenocarcinoma which produces mucin. The World Health Organization has classified MAC as a tumor of salivary gland origin and it is extremely rare. Therefore, its characteristics are not well-known. This study reports a case of MAC of minor salivary gland origin, which occurred in the oral commissure of an 82-year-old female patient, and a systematic review on existing cases of MAC of salivary origin. Based on the study’s findings, it is safe to assume that the occurrence of lymph node metastasis is an important factor in determining the prognosis of patients with MAC.

본 연구는 췌장암 환자가 수술 후 보조 요법으로서 항암화학요법 또는 항암-방사선병용요법을 시행받는 경우에 있어서 치료 성적의 차이가 있는지 조사하기 위해 시행하였다. 2008년에서 2012년까지 부산대학교병원에서 수술을 시행한 40명의 췌장 선암 환자들의 의무기록을 조사하였다. 근치적 목적으로 수술을 받은 환자 중 29명이 항암화학 요법 또는 항암-방사 선병용요법의 보조요법을 시행받았다. 보조요법의 시행 (p =0.025)과 완전 절제(p =0.043)가 더 긴 전체 생존기간과 연관이 있었다. 보조요법으로서 항암화학요법을 시행한 군과 항암-방사선병용요법을 시행한 군에서 전체 생존 기간은 유의하게 다르지 않았으나 보조요법을 하지 않은 군과 비교하였을 때에는 보조요법으로 항암화학요법을 시행한 군에서 유의하게 높은 전체 생존율을 보였다. 수술 후 보조요법은 췌장 선암 환자의 예후를 향상시키며, 항암화학요법이 항암-방사선 병용요법보다 양호한 결과를 보인다.

A 2-year-old female Maltese dog was presented with a history of anemia and vaginal hemorrhagic discharge. Physical examination revealed severe vaginal hemorrhagic discharge, abdominal pain, pale mucous membranes, low blood pressure and dehydration. Results of serum biochemistry, hematology, venous blood gas, and electrolyte canine C-reactive protein (CRP) test revealed severe normocytic normochromic anemia, severe neutropenia, a high level of CRP, hypoglycemia, and imbalanced electrolytes. Abdominal ultrasound examination showed focal hypoechoic defect with loss of layering in uterine horn wall. A laparotomy revealed a clear reddish fluid in the abdomen, the fistula of left and right uterine horn, the purulent discharge from fistula, and symptoms of septic peritonitis near by the fistula site. The bitch underwent ovariohysterectomy and recovered without complication. Histopathological diagnosis of the uterine fistula site was adenocarcinoma.

A 2-year-old female Maltese dog was admitted with a history of pyometra and resulting peritonitis and septicemia. Uterine specimen sampled by ovariohysterectomy was processed routinely for histopathological observation. Grossly, the uterine mucosa was covered with necrotic debris and on the cut surface, lesion extended into the uterine wall. Microscopically, severe necrosis was observed throughout thickened mucosa, submucosa, and wall of uterus. Tumorous lesions composed of anaplastic cells with bizarre nuclei or tubular structures of cuboidal to short columnar cells were infrequently observed around the necrotic lesions and muscular layer far from necrotic areas. Immunohistochemically, central necrotic area with ambiguous cell and tissue structures, peri-necrotic tumor lesions, and muscular layer were strongly positive for cytokeratin. Since huge necrosis of adenocarcinoma lesions in this case made it difficult to diagnose, immunohistochemical results enable to diagnose as a severe necrotizing adenocarcinoma. Thus, histopathological and immunohistochemical findings in this case may serve as an important knowledge to diagnose uterine adenocarcinoma with huge necrosis in the veterinary field.

배경/목적: 바터팽대부에서 발생하는 선암종은 드문 질환으로 항암화학요법에 대한 연구가 부족하다. 본 연구에서 진 행성 바터팽대부 선암종 환자에서 XELOX 병합요법의 효능 및 안전성을 분석하고자 한다. 방법: 2006년 10월부터 2014년 1월까지 국립암센터에서 XELOX 병합요법으로 치료한 바터팽대부 선암종 환자 28명 을 대상으로 후향적으로 분석하였다. 모든 환자는 진단 당시 전이성 또는 재발한 바터팽대부 선암종 환자이었다. XELOX 병합요법은 외래에서 3주마다 다음과 같은 프로토콜에 따라 투여되었다. 치료 시작 1-14일에 하루 2회 카페시타빈 750 mg/m2를 경구 투여하고, 1일에 옥살리플라틴 130 mg/m2을 정맥 주사하였다. 결과: 24.6개월(범위 4.8-78개월)의 중앙 추적관찰 기간에서 중앙 무진행 생존 기간은 4.8개월(범위 0.7-18.0개월)이었고, 중앙 생존 기간은 11.9개월(범위 2.0–26.1개월)이었다. 1명의 환자(4%)가 완전 관해를 얻었고, 5명의 환자(18%)는 부분 관 해를 보였다. 무진행 생존 기간와 전체 생존 기간에서 항암화 학요법 반응 여부에 따른 차이는 없었다. 환자에서 가장 흔한 3등급의 이상 반응은 메스꺼움과 구토였다(10.7%). 치료와 관 련된 사망은 관찰되지 않았다. 결론: XELOX 요법은 전이 혹은 재발 바터팽대부 선암종에서 비교적 낮은 독성의 발현과 중등도 효과를 보이는 치료법이다.

As a result of development in medical diagnostic technology, the incidence of double primary cancer is increasing. In case that one primary cancer was identified by pathologic finding and has suggestive multiple metastatic lesions of the cancer, it is often difficult that the lesions are considered as another synchronous primary malignancy, not as metastasis of primary cancer. Here, we report a rare case of synchronous double primary renal cell carcinoma that was diagnosed initially as metastatic duodenal adenocarcinoma. A 66-year-old man presented with a palpable abdominal mass. Abdominal computed tomography showed duodenal wall thickening and hypervascular masses in the liver and left kidney. Esophagogastroduodenoscopy revealed an ulcerative lesion in the duodenal bulb, and endoscopic biopsy identified moderately-differentiated adenocarcinoma. We regarded the findings as duodenal adenocarcinoma with metastasis to liver and kidney. So he was treated with fluoropyrimidine-based chemotherapy for the diagnosis of duodenal adenocarcinoma with liver and renal metastases. After 10 months, he developed a right forearm mass. Morphological and immunohistochemical analysis of an incisional biopsy of the forearm mass were consistent with a diagnosis of metastatic renal cell carcinoma. Even when there is a pathologically confirmed malignancy, clinicians must consider the possibility of synchronous double primary malignancy in metastatic lesions.

특발성 재발성 췌장염은 원인 질환을 찾기 위한 다양한 접근이 필요한데 이 중 바터 팽대부내 종양의 경우에는 영 상학적 검사 외에도 내시경적 유두절개술을 통한 조직검사 와 같은 적극적인 원인 질환의 규명이 필요하겠다. 저자들 은 황달과 같은 담관 폐색에 의한 증상 없이 반복적인 췌장 염만 나타난 환자에서 바터 팽대부내선암을 경험하였기에 이를 보고한다.

75세 남자환자가 3개월 전부터 지속된 복부 불편감과 식욕 저하로 병원을 방문하였고, 복부전산화단층촬영을 시행한 결과 췌장 발육 부전증과 췌장 두부의 종괴, 복막의 비후가 관찰되었다. 자기공명담췌관촬영술과 내시경역행담췌관 조영술에서 주 췌관은 정상이었으나 췌부와 미부의 췌관 및 산토리니관은 관찰되지 않았다. 양전자방출단층촬영에서 복막과 폐의 암전이 소견이 나타났으며, 복수천자에서 얻은 세포검사에서 선암종이 확인되어 타 장기의 전이가 진행된 췌장암을 진단하였다. 이에 저자는 췌장암이 동반된 배측 췌장 발육 부전증 1예를 보고하는 바이다.

As the designated name, adenocarcinoma, not otherwise specific (ANOS) revealed lack of histomorphologic characteristics that could classify the tumors under specific name. ANOS had nothing in common with other salivary gland malignancies, but glandular differentiation. The purpose of this study is to find out the solid characteristics of ANOS on the base of cytological and architectural features. 20 ANOS cases were studied. We identified 20 patients with salivary adenocarcinoma, not otherwise specified, ranging in age from 26 to 76 years (median, 53.85 years), with slight female predilection (female 11: male 9). The minor salivary gland was the most common site of tumor origin, especially on the palatal area (11 out of 20). The size of tumor was from 1.0 to 7.0(median 3.07). For the histopathological analysis, we classified the tumors by cytological and architecture patterns. Basaloid and epitheloid cytological patterns were showed with solid, microcystic/pseudocystic architecture. We found invasive growth patterns in 7 out of 20 cases. Reviewing and classifying the common features of ANOS could be helpful to make a diagnosis of malignant salivary gland tumors.

Clear cell adenocarcinoma (CCA) is a rare malignant neoplasm of salivary gland that represents only 1% of all salivary gland tumors. CCA is histopathologically characterized by monotonous, glycogen-rich, round to ovoid clear cells intermixed with hyalinized stroma. However, other salivary gland tumors such as mucoepidermoid carcinoma, acinic cell adenocarcinoma, oncocytoma, epithelial-myoepithelial carcinoma, and myoepithelial carcinoma should be ruled out to diagnosis CCA. We herein report a case of CCA involving the soft palate in a 56-year-old female. It is essential to consider CCA in the differential diagnoses of clear cell tumors.

A 78 year-old male complained of mild pain at a gingival mass on his anterior mandible, injured and ulcerated by autobicycle accident six months ago. He had suffered from uncontrolled diabetes. The tumor specimens from his chin and gingiva were examined by immunohistochemical method, and their microsections showed poorly differentiated polygonal tumor cells, occasionally formed ductal structures. The tumor cells grew infiltratively into adjacent fibromuscular tissue with frequent atypical mitosis, exhibiting the features of poorly differentiated adenocarcinoma. However, in the computed tomography(CT) view a tumor mass was also found in his lung, and diagnosed lung cancer. In the immunohistochemical observation the tumor cells were strongly positive for thyroid transcription factor 1(TTF-1), cytokeratin 7, PCNA, p53, and PIM-1, occasionally positive for p63, but sparsely positive for survivin. The tumor cells were almost negative for S-100, cytokeratin 14, and α-SMA, while the vascular structures in the tumor tissue were conspicuously demarcated by the stains of α-SMA. Taken together, the present case was finally diagnosed poorly differentiated adenocarcinoma, metastasized from lung adenocarcinoma. And it was presumed that the metastatic tumor cells tended to be anchored in the traumatized area of anterior mandible, where the wound healing was undergoing with de novo angiogenesis and the activation of different cytokines and growth factors

Malignant pleural effusion (MPE) and blood samples can be used as a practical source for detection of epidermal growth factor receptor (EGFR) mutations in patients with advanced non-small cell lung cancer. We compared EGFR mutation status of cell blocks, cell-free fluid of MPE, and plasma from patients with lung adenocarcinoma. We obtained paired samples of MPE and plasma from 14 pathologically-confirmed lung adenocarcinoma patients. Peptide nucleic acid (PNA)-mediated real-time polymerase chain reaction (RT-PCR) clamping was performed for determination of EGFR mutation status. EGFR mutations were detected in five (35.7%) cell blocks of MPE, which showed results identical to those of the corresponding cell-free fluid, whereas mutations were detected in the plasma of only two (40.0%) of the five patients. Of seven patients treated with EGFR tyrosine kinase inhibitors (TKIs), EGFR mutations were detected in cell blocks, cell-free fluid of MPE, and plasma for only one of the four patients who responded to EGFR TKIs, while mutations were detected only in cell blocks of MPE and cell-free fluid of the three remaining patients. Our results suggest that detection of EGFR mutations in cell-free pleural fluid from lung adenocarcinoma patients using highly sensitive methods may be feasible, but that analysis of free plasma may lead to undetected mutations and misdiagnosis.

The osteoblastic activity of carcinoma is restricted in osteoblastic metastasis, common in the patients with prostate cancer, whereas its mechanism and the factors involved are unknown. Here, we present a case of central adenocarcinoma showing the osteoblastic activity in the mandible of the 80-year-old Korean male who had suffered from the paresthesia of lower lip during four mouths. Clinically the overlying oral epithelium was intact, but the radiologic images revealed the ill-defined radiolucent intraosseous lesions in left ascending ramus. Microscopically, the mandibular lesion was composed with carcinoma of ductal or glandular differentiation but lack typical features of any epithelial salivary gland malignancies. Intriguingly abundant new bone formation was found in the stroma, but the tumor cells expressed no reactivity for prostate-specific antigen(PSA). The patient had low ionized calcium level, normal serum alkaline phosphatase and PSA level. Positron emission tomography-computed tomopraphy scan revealed the benign prostatic hyperplasia, but failed to trace the primary site of tumor other than mandible. Therefore, pathologically diagnosis for the lesion was informed as adenocarcinoma, not otherwise specified(NOS). Because occult primary tumor associated with osteoblastic metastasis cannot be completely ruled out, periodic and careful check-ups for the patient should be performed.

The phytochemicals of many plants suggest their potential use as dietary supplements in cancer chemoprevention and chemotherapy. In the present study, antitumor activity of Cudrania tricuspidata, a plant native to East Asia, was investigated. Cell growth inhibition of the extract on HT-29 colorectal adenocarcinoma using MTT colorimetric assay was determined. Apoptosis on HT-29 cells was performed by DNA fragmentation analysis. PGE2 release was measured by enzyme immunoassay, because PGE2 is a key protumorigenic prostanoid in many human cancers. For the ROS scavenging activity, ROS level was detected by laser scanning confocal microscope. It was found that methanol extract of leaves inhibits cell viability by inducing apoptosis as evidenced by DNA fragmentation. Stem bark decreases synthesis of PGE2, inflammatory mediator. Fruits exhibited pronounced ROS scavenging activity. Taken together, these results suggest that Cudrania tricuspidata exerts growth inhibition and anti-oxidation on HT-29 cells through apoptosis, ROS scavenging respectively that it may have anti-cancer properties.

Established SGT cell line from human submandibular gland adenocarcinoma was used to study the TGase expression on a cellular level in vitro. Transglutaminase 2(TGase 2) is assoacitated with apoptosis, GTP binding protein, and cell marix interaction. The role of TGase 2 in salivary gland tumors is not clear yet. The pupose of this study were to examine the TGase expression of SGT cell line compared to other tumor cell lines, and to apply these results to the pathogenesis of salivary gland tumor. TGase enzyme assay of SGT, SCC-15, HN 4 and HeLa tumor cell line was 3 times repeated, and calculated. Immunoslot blot for semiquantitative protein analysis was done. The obtained results were as follows. 1. SGT cell line showed the highest TGase 2 enzyme activity(about 6-16 folds) irrespective of pre or postconfluency. 2. HN 4 cell line showed the highest TGase 1 enzyme activity(about 2-3 folds) irrespective of pre or postconfluency. 3. Under postconfluency TGase 1 induction was not induced, but slightly increased in all tumor cell lines. 4. TGase enzyme activity in all tumor cell lines was accompanied with TGase protein formation. From the aboving results, the higher TGase 2 expression of SGT cell line suggested that they would come from submandibular ductal cells and have a important role in the pathogensis of salivary gland tumors.